New historical and regulatory milestone for cannabis in Brazil: ANVISA publishes new RDCs (Collegiate Board Resolutions) and advances the regulation of medicinal cannabis.
The Collegiate Board Resolutions (RDC) No. 1,011/2026, No. 1,012/2026, No. 1,013/2026, No. 1,014/2026, and No. 1,015/2026 were published in the Official Gazette of the Union, establishing provisions on cannabis regulation in Brazil.
Public Consultation on Medicinal Cannabis Products: Anvisa’s Main Proposals
As of April 4, 2025, Anvisa launched a public consultation (CP 1.316/2025) to update the rules on cannabis products for medicinal use in Brazil.
Public Consultation on the Revision of RDC 327/2019: Main Changes and Criticisms
On March 26, 2025, the public consultation on the revision of RDC 327/2019, which regulates the health authorization, manufacture, import, marketing, prescription and inspection of cannabis-based products for medicinal purposes in Brazil, was approved.